CD4 and gastric cancer: Additionally, a meta-analysis was conducted to evaluate the efficacy and safety of SJZD combined with enteral nutrition in GC patients, resulting in significant improvements in albumin, prealbumin, transferrin, immunoglobulin, CD3+, CD4+, and CD4+/CD8+ (Chen et al., 2020).